An observational study in Epididymal Cyst and Vas Deferens; Anomaly, sponsored by Aswan University Hospital. Completed at 1 site in Egypt. Open to male participants aged 8 Months to 125 Weeks. Per ClinicalTrials.gov, last updated 2021-01-06.
Sponsored by Aswan University Hospital · Observational
Among 17 studies in Congenital Abnormalities with a site in Egypt — 1 open to participants now, 2 under way, none of them phase 3. Congenital Abnormalities · Egypt.
Among the 17 studies in Congenital Abnormalities with a site in Egypt, this one is one of 2 that started in 2017, is one of 9 observational ones, and was the 7th registered.
781 studies on the registry are indexed under Congenital Abnormalities; 77 are open to participants now.
This study's enrollment of 22 is below the median of 250 across 257 observational studies indexed under Congenital Abnormalities.
Browse Congenital Abnormalities studies →1 of the 17 studies in Congenital Abnormalities with a site in Egypt is open now, in 1 country. Each count lists the studies.
Of the 60 Congenital Abnormalities studies recruiting now, 27 (45%) set no upper age limit and 27 (45%) stop at 75 or younger; 35 take children under 18; 22 take healthy volunteers.
This study: 8 Months to 125 Weeks · male.
The full table on the hub →17 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 2 started in 2017.
Median enrollment 23 across the 8 interventional studies, 250 across the 9 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
None of the 17 has an industry lead sponsor. The 10 most frequent:
Aswan University Hospital is the lead sponsor of 97 studies on the registry; 3 are open to participants now.
Aswan University Hospital has 1 study filed under Congenital Abnormalities — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 17 studies in Congenital Abnormalities with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
: Data was collected retrospectively from six centers providing care for patients with undescended testicles from September 2017 to February 2019. All patients whose congenital anomalies of the epididymis or vas deferens were discovered incidentally during operative intervention for cryptorchidism and where photographs of the anomalies were taken were included.
Background: Epididymal and vas deferens anomalies are not rare among children with cryptorchidism. They may affect fertility following orchiopexy.
Material and Methods: Data was collected retrospectively from six centers providing care for patients with undescended testicles from September 2017 to February 2019. All patients whose congenital anomalies of the epididymis or vas deferens were discovered incidentally during operative intervention for cryptorchidism and where photographs of the anomalies were taken were included.
We retrospectively collected data from patients with anomalies of the epididymis or vas deferens. These anomalies were discovered incidentally during operative intervention for cryptorchidism
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
collection of cases
retrospective from multicenter university hospital
Time frame: one and half year
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Sep 2017 to primary completion in Feb 2019, 17 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aswan University Hospital